pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative ColitisA Longitudinal Report from the IBD Porto Group of ESPGHAN

被引:30
作者
Birimberg-Schwartz, Liron [1 ]
Wilson, David C. [2 ]
Kolho, Kaija-Leena [3 ]
Karolewska-Bochenek, Katarzyna [4 ]
Afzal, Nadeem Ahmad [5 ]
Spray, Christine [6 ]
Romano, Claudio [7 ]
Lionetti, Paolo [8 ]
Hauer, Almuthe C. [9 ]
Martinez-Vinson, Christine [10 ]
Veres, Gabor [11 ]
Escher, Johanna C. [12 ]
Turner, Dan [13 ]
机构
[1] Shaare Zedek Med Ctr, Jerusalem, Israel
[2] Univ Edinburgh, Child Life & Hlth, Edinburgh EH8 9YL, Midlothian, Scotland
[3] Univ Helsinki, FIN-00014 Helsinki, Finland
[4] Med Univ, Dept Pediat Gastroenterol, Warsaw, Poland
[5] Southampton Univ Hosp, Southampton, Hants, England
[6] Univ Hosp Bristol, Bristol, Scotland
[7] Univ Messina, I-98100 Messina, Italy
[8] Univ Florence, I-50121 Florence, Italy
[9] Med Univ Graz, Univ Hosp Pediat & Adolescent Med, Graz, Austria
[10] Robert Debre Hosp, Dept Pediat Gastroenterol & Nutr, Paris, France
[11] Semmelweis Univ, Budapest, Hungary
[12] Erasmus MC, Rotterdam, Netherlands
[13] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel
基金
英国医学研究理事会;
关键词
pediatrics; IBDU; Crohn's colitis; UC; ANCA; ASCA; prediction; INFLAMMATORY-BOWEL-DISEASE; ANTI-SACCHAROMYCES-CEREVISIAE; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; SEROLOGICAL MARKERS; INDETERMINATE COLITIS; CLINICAL-COURSE; DIAGNOSIS; UTILITY; RISK; AUTOANTIBODIES;
D O I
10.1097/MIB.0000000000000784
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction:No study to date has evaluated perinuclear antineutrophil cytoplasmic antibody (pANCA) and anti-Saccharomyces cerevisiae antibody (ASCA) in pediatric inflammatory bowel disease-unclassified (IBDU) as compared with Crohn's colitis (CC) and ulcerative colitis (UC), which represent the diagnostic challenge. We aimed to explore the diagnostic utility of serology and to assess whether serology can predict disease severity in these subgroups.Methods:This was a multicenter retrospective longitudinal study including 406 children with inflammatory bowel diseases (IBD) from 23 centers affiliated with the Porto group of European Society of Pediatric Gastroenterology, Hepatology and Nutrition (mean age 10.5 3.9, 54% males); 117 (29%) with CC, 143 (35%) with UC, and 146 (36%) with IBDU. Median follow-up period was 2.8 years (interquartile range, 1.6-4.2).Results:The most prevalent serologic profile in IBDU was pANCA-/ASCA- (41%), followed by pANCA+/ASCA- (34%) and pANCA-/ASCA+ (17%). pANCA-/ASCA+ differentiated well between CC versus IBDU (83% specificity, 96% positive predictive value [PPV]) and UC (97% specificity, 90% PPV) patients, albeit with a low negative predictive value (13% and 40%, respectively). pANCA+/ASCA- did not differentiate as well between IBD subgroups, but UC children with pANCA+/ASCA- had more often severe disease at diagnosis (36 [62%] versus 22 [38%], P = 0.033) and needed more often calcineurin inhibitors, biologics, or colectomy (25 [80%] versus 6 [20%], P = 0.026). In CC, double positivity for ASCA and not pANCA-/ASCA+ profile was associated with disease severity.Conclusions:Serology may have some role in predicting disease course and outcomes in colonic IBD, but its routine use needs to be supported by more studies. Serology cannot routinely be recommended for differentiating between IBDU versus CC or UC as a sole diagnostic criterion given its low diagnostic utility.
引用
收藏
页码:1908 / 1914
页数:7
相关论文
共 31 条
  • [1] Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
    Anderson, Carl A.
    Boucher, Gabrielle
    Lees, Charlie W.
    Franke, Andre
    D'Amato, Mauro
    Taylor, Kent D.
    Lee, James C.
    Goyette, Philippe
    Imielinski, Marcin
    Latiano, Anna
    Lagace, Caroline
    Scott, Regan
    Amininejad, Leila
    Bumpstead, Suzannah
    Baidoo, Leonard
    Baldassano, Robert N.
    Barclay, Murray
    Bayless, Theodore M.
    Brand, Stephan
    Buening, Carsten
    Colombel, Jean-Frederic
    Denson, Lee A.
    De Vos, Martine
    Dubinsky, Marla
    Edwards, Cathryn
    Ellinghaus, David
    Fehrmann, Rudolf S. N.
    Floyd, James A. B.
    Florin, Timothy
    Franchimont, Denis
    Franke, Lude
    Georges, Michel
    Glas, Juergen
    Glazer, Nicole L.
    Guthery, Stephen L.
    Haritunians, Talin
    Hayward, Nicholas K.
    Hugot, Jean-Pierre
    Jobin, Gilles
    Laukens, Debby
    Lawrance, Ian
    Lemann, Marc
    Levine, Arie
    Libioulle, Cecile
    Louis, Edouard
    McGovern, Dermot P.
    Milla, Monica
    Montgomery, Grant W.
    Morley, Katherine I.
    Mowat, Craig
    [J]. NATURE GENETICS, 2011, 43 (03) : 246 - U94
  • [2] Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region
    Barrett, Jeffrey C.
    Lee, James C.
    Lees, Charles W.
    Prescott, Natalie J.
    Anderson, Carl A.
    Phillips, Anne
    Wesley, Emma
    Parnell, Kirstie
    Zhang, Hu
    Drummond, Hazel
    Nimmo, Elaine R.
    Massey, Dunecan
    Blaszczyk, Kasia
    Elliott, Timothy
    Cotterill, Lynn
    Dallal, Helen
    Lobo, Alan J.
    Mowat, Craig
    Sanderson, Jeremy D.
    Jewell, Derek P.
    Newman, William G.
    Edwards, Cathryn
    Ahmad, Tariq
    Mansfield, John C.
    Satsangi, Jack
    Parkes, Miles
    Mathew, Christopher G.
    Donnelly, Peter
    Peltonen, Leena
    Blackwell, Jenefer M.
    Bramon, Elvira
    Brown, Matthew A.
    Casas, Juan P.
    Corvin, Aiden
    Craddock, Nicholas
    Deloukas, Panos
    Duncanson, Audrey
    Jankowski, Janusz
    Markus, Hugh S.
    McCarthy, Mark I.
    Palmer, Colin N. A.
    Plomin, Robert
    Rautanen, Anna
    Sawcer, Stephen J.
    Samani, Nilesh
    Trembath, Richard C.
    Viswanathan, Ananth C.
    Wood, Nicholas
    Spencer, Chris C. A.
    Bellenguez, Celine
    [J]. NATURE GENETICS, 2009, 41 (12) : 1330 - U99
  • [3] Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
    Brand, S.
    [J]. GUT, 2009, 58 (08) : 1152 - 1167
  • [4] Indeterminate colitis: A significant subgroup of pediatric IBD
    Carvalho, RS
    Abadom, V
    Dilworth, HP
    Thompson, R
    Oliva-Hemker, M
    Cuffari, C
    [J]. INFLAMMATORY BOWEL DISEASES, 2006, 12 (04) : 258 - 262
  • [5] Recent Insights Into the Genetics of Inflammatory Bowel Disease
    Cho, Judy H.
    Brant, Steven R.
    [J]. GASTROENTEROLOGY, 2011, 140 (06) : 1704 - U21
  • [6] Utility of Serum Antibodies in Determining Clinical Course in Pediatric Crohn's Disease
    Desir, Barbara
    Amre, Devendra K.
    Lu, Shou-En
    Ohman-Strickland, Pamela
    Dubinsky, Marla
    Fisher, Rachel
    Seidman, Ernest G.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (02) : 139 - 146
  • [7] Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
    Dubinsky, Marla C.
    Kugathasan, Subra
    Mei, Ling
    Picornell, Yoana
    Nebel, Justin
    Wrobel, Iwona
    Quiros, Antonio
    Silber, Gary
    Wahbeh, Ghassan
    Katzir, Lirona
    Vasiliauskas, Eric
    Bahar, Ron
    Otley, Anthony
    Mack, David
    Evans, Jonathan
    Rosh, Joel
    Hemker, Maria Oliva
    Leleiko, Neal
    Crandall, Wallace
    Langton, Christine
    Landers, Carol
    Taylor, Kent D.
    Targan, Stephan R.
    Rotter, Jerome I.
    Markowitz, James
    Hyams, Jeffrey
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (10) : 1105 - 1111
  • [8] Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression
    Dubinsky, MC
    Lin, YC
    Dutridge, D
    Picornell, Y
    Landers, CJ
    Farrior, S
    Wrobel, I
    Quiros, A
    Vasiliauskas, EA
    Grill, B
    Israel, D
    Bahar, R
    Christie, D
    Wahbeh, G
    Silber, G
    Dallazadeh, S
    Shah, P
    Thomas, D
    Kelts, D
    Hershberg, RM
    Elson, CO
    Targan, SR
    Taylor, KD
    Rotter, JI
    Yang, HY
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02) : 360 - 367
  • [9] New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
    Ferrante, Marc
    Henckaerts, Liesbet
    Joossens, Marie
    Pierik, Marie
    Joossens, Sofie
    Dotan, Nir
    Norman, Gary L.
    Altstock, Rom T.
    Van Steen, Kristel
    Rutgeerts, Paul
    Van Assche, Gert
    Vermeire, Severine
    [J]. GUT, 2007, 56 (10) : 1394 - 1403
  • [10] Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease
    Forcione, DG
    Rosen, MJ
    Kisiel, JB
    Sands, BE
    [J]. GUT, 2004, 53 (08) : 1117 - 1122